| Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine. | |
| | |
MedLine Citation:
|
PMID: 20950809 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Enzymatic degradation of the extracellular matrix is known to be powerful regulator of atherosclerosis. However, little is known about the enzymatic regulation of heparan sulfate proteoglycans (HSPGs) during the formation and progression of atherosclerotic plaques. METHODS AND RESULTS: Swine were rendered diabetic through streptozotocin injection and hyperlipidemic through a high fat diet. Arterial remodeling and local endothelial shear stress (ESS) were assessed using intravascular ultrasound, coronary angiography and computational fluid dynamics at weeks 23 and 30. Coronary arteries were harvested and 142 arterial subsegments were analyzed using histomorphologic staining, immunostaining and real time PCR. Heparanase staining and activity was increased in arterial segments with low ESS, in lesions with thin cap fibroatheroma (TCFA) morphology and in lesions with severely degraded internal elastic laminae. In addition, heparanase staining co-localized with staining for CD45 and MMP-2 within atherosclerotic plaques. Dual staining with gelatinase zymography and heparanase immunohistochemical staining demonstrated co-localization of matrix metalloprotease activity with heparanase staining. A heparanase enzymatic activity assay demonstrated increased activity in TCFA lesions, subsegments with low ESS and in macrophages treated with oxidized LDL or angiotensin II. CONCLUSIONS: Taken together, our results support a critical role for heparanase in the development of vulnerable plaques and suggest a novel therapeutic target for the treatment of atherosclerosis. |
| | |
Authors:
|
Aaron B Baker; Yiannis S Chatzizisis; Roy Beigel; Michael Jonas; Benjamin V Stone; Ahmet U Coskun; Charles Maynard; Campbell Rogers; Konstantinos C Koskinas; Charles L Feldman; Peter H Stone; Elazer R Edelman |
Related Documents
:
|
6870609 - Neurologic symptoms associated with nonobstructive plaque at carotid bifurcation. analy... 20418769 - Atherosclerotic plaque composition among patients with stenotic coronary artery disease... 17526989 - Accuracy of nonstenotic coronary atherosclerosis assessment by multi-detector computed ... 2137149 - Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy... 11930069 - Techniques for the detection of coronary atherosclerosis: multi-detector row ct coronar... 1499179 - Anatomy, histology, and pathology of coronary arteries: a review relevant to new interv... 14992939 - Total right ventricular dependent coronary circulation in pulmonary atresia with intact... 15086229 - Comparison of routine and selective use of intraoperative angiography during aneurysm s... 2067589 - Release of endogenous catecholamines in two different regions of the nucleus of the sol... |
Publication Detail:
|
Type: Journal Article Date: 2010-09-18 |
Journal Detail:
|
Title: Atherosclerosis Volume: 213 ISSN: 1879-1484 ISO Abbreviation: Atherosclerosis Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-12-06 Completed Date: 2011-03-18 Revised Date: 2013-05-27 |
Medline Journal Info:
|
Nlm Unique ID: 0242543 Medline TA: Atherosclerosis Country: Ireland |
Other Details:
|
Languages: eng Pagination: 436-42 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved. |
Affiliation:
|
Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, United States. abbaker@austin.utexas.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antigens, CD45 / metabolism Coronary Artery Disease / metabolism*, pathology Diabetes Mellitus, Experimental / enzymology* Dietary Fats / administration & dosage Gene Expression Regulation, Enzymologic Glucuronidase / biosynthesis* Heparan Sulfate Proteoglycans / metabolism Hyperlipidemias / enzymology* Male Matrix Metalloproteinase 2 / metabolism Plaque, Atherosclerotic / enzymology Swine |
| Grant Support | |
ID/Acronym/Agency:
|
R01 GM049039-15/GM/NIGMS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Dietary Fats; 0/Heparan Sulfate Proteoglycans; EC 3.1.3.48/Antigens, CD45; EC 3.2.1.-/heparanase; EC 3.2.1.31/Glucuronidase; EC 3.4.24.24/Matrix Metalloproteinase 2 |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Coronary bare metal stent implantation in homozygous LDL receptor deficient swine induces a neointim...
Next Document: Deficiency of macrophage migration inhibitory factor gene delays healing of the medial collateral li...